Equities

CeCors Inc

CEOS:PKL

CeCors Inc

Actions
  • Price (USD)0.0264
  • Today's Change-0.005 / -16.19%
  • Shares traded2.60m
  • 1 Year change+88.57%
  • Beta0.5236
Data delayed at least 15 minutes, as of Nov 22 2024 18:19 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CeCors, Inc., through its wholly owned subsidiary, PsyKey Inc., is vertically integrated in the research and development, production and commercialization of therapeutic and medicinal entheogenic, adaptogenic, nootropic ingredients and formulations for its functional product lines which are developed by its mycology and botany experts. PsyKey Inc. understands the importance of access to support services and healthcare professionals and is continuously engaged in the development of tools that will aid in removing barriers and providing inclusivity. PsyKey Inc. is also engaged in the scientific development of patentable technologies pertaining to the composition, bioavailability and targeted delivery of entheogen-based therapeutics. It produces functional mushroom-based products. Its products consist of infused coffee blends and capsule supplements. Its subsidiary is VETCOMM, which is a provider of Veterans Affairs (VA) benefits courses and services offers ad hoc claims support services.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2002
  • Employees6.00
  • Location
    CeCors Inc854 Upper Canada DriveSARNIA N7W 1A4CanadaCAN
  • Phone+1 (480) 659-8036
  • Fax+1 (714) 768-8737
  • Websitehttps://www.cecorsinc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
BioCardia Inc71.00k-7.72m9.79m16.00--3.51--137.85-4.22-4.220.0360.60860.0142--1.254,437.50-154.22-107.34-401.77-154.17-----10,876.06-1,779.24----0.00---64.72-5.262.82---28.89--
Kiora Pharmaceuticals Inc16.02m5.55m9.93m12.005.410.33081.780.62-0.5993-0.59934.8910.010.5889--9.181,335,000.0020.40-70.5222.75-81.86----34.64-2,040.61----0.00------3.97------
BioRestorative Therapies Inc377.00k-6.17m10.00m11.00--1.00--26.52-0.7135-0.71350.05461.440.0266--3.6934,272.73-43.49-192.11-53.99-329.3279.04---1,636.79-19,116.15----0.00--21.705.6143.67--67.77--
Imunon Inc0.00-19.45m10.05m33.00--1.23-----1.89-1.890.000.56490.00----0.00-99.63-50.18-137.53-60.27-------5,725.88----0.00---100.00--45.64--26.69--
Vaccinex Inc388.00k-18.58m10.06m37.00------25.93-12.15-12.150.2512-0.50810.1047--0.404610,486.49-501.27-262.29---------4,787.89-4,257.17---49.48----107.27-4.67-2.20---22.20--
Dominari Holdings Inc12.59m-22.69m10.23m26.00--0.2673--0.8126-3.85-3.852.116.100.2361--3.80484,192.30-42.55-26.82-44.27-27.45-----180.22-3,353.52---4.830.00----135.7512.72--63.99--
Oncotelic Therapeutics Inc0.00-4.66m10.31m22.00--1.17-----0.0115-0.01150.000.02170.00----0.00-17.29-25.03-39.98-48.76-------1,692.93---0.50090.614-------255.12------
ELEVAI Labs Inc2.45m-5.47m10.46m18.00--0.1166--4.27-0.2924-0.29240.13030.17330.38260.9499216.67135,897.80-85.53---121.34--71.15---223.57--3.40--0.00--123.50---138.94------
CeCors Inc-100.00bn-100.00bn10.46m6.00---------------0.0163------------------------------------22.70------
Indaptus Therapeutics Inc0.00-14.89m10.66m7.00--1.77-----1.72-1.720.000.58870.00----0.00-114.42-66.55-138.96-81.23------------0.00-------7.68------
Viaderma Inc17.80m2.31m10.73m75.000.00050.000031.980.60316.8416.84129.62255.590.412624.691.21237,331.305.36--6.53--28.90--12.99--2.075.660.1718---29.15---40.70------
Turnstone Biologics Corp0.00-74.42m10.86m81.00--0.2488-----3.23-3.230.001.890.00----0.00-78.42---91.27--------------0.00---73.66---78.05------
Nascent Biotech Inc0.00-1.92m10.93m-----------0.012-0.0120.00-0.0030.00-------1,256.81-708.50-----------589.83------------25.47------
Conduit Pharmaceuticals Inc0.00-13.62m11.10m7.00---------0.1708-0.17080.00-0.0950.00----0.00-181.43-----------------20.00--------89.05------
Data as of Nov 22 2024. Currency figures normalised to CeCors Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.